Acute Escherichia coli prostatitis in previously health young men: Bacterial virulence factors, antimicrobial resistance, and clinical outcomes

Urology

Volumn 77, Issue 6, 2011, Pages 1420-1425

  Krieger, John N ^a,b,c,d   Dobrindt, Ulrich ^a,b,c,d   Riley, Donald E ^a,b,c,d   Oswald, Eric ^a,b,c,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; COLIBACTIN; COTRIMOXAZOLE; CYTOLETHAL DISTENDING TOXIN; CYTOTOXIC NECROTIZING FACTOR 1; LEVOFLOXACIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; ESCHERICHIA COLI; HUMAN; MALE; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATITIS; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT FUNCTION;

ACUTE DISEASE; ADOLESCENT; ADULT; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; MALE; PHENOTYPE; PROSTATITIS; TREATMENT OUTCOME; URINARY TRACT; VIRULENCE; VIRULENCE FACTORS;

EID: 79957902715     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.12.059     Document Type: Article

References (30)

1. Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in healthy university men. J Urol. 1993;149:1046-1048. (Pubitemid 23133767)
2. Abarbanel J, Engelstein D, Lask D, et al. Urinary tract infection in men younger than 45 years of age: is there a need for urologic investigation? Urology. 2003;62:27-29. (Pubitemid 36802065)
3. Krieger JN, Nyberg L Jr., Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236-237. (Pubitemid 29343164)
4. Dowling KJ, Roberts JA, Kaack MB. P-fimbriated Escherichia coli urinary tract infection: a clinical correlation. South Med J. 1987; 80:1533-1536. (Pubitemid 18055414)
5. Dalet F, Segovia T, Del Rio G. Frequency and distribution of uropathogenic Escherichia coli adhesins: a clinical correlation over 2,000 cases. Eur Urol. 1991;19:295-303.
6. Terai A, Yamamoto S, Mitsumori K, et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol. 1997;4:289-294. (Pubitemid 127494968)
7. Andreu A, Stapleton AE, Fennell C, et al. Urovirulence determinants in Escherichia coli strains causing prostatitis. J Infect Dis. 1997;176:464-469. (Pubitemid 27328770)
8. Mitsumori K, Terai A, Yamamoto S, et al. Virulence characteristics of Escherichia coli in acute bacterial prostatitis. J Infect Dis. 1999; 180:1378-1381. (Pubitemid 30070233)
9. Ruiz J, Simon K, Horcajada JP, et al. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol. 2002;40:4445-4449. (Pubitemid 35434929)
10. Ishitoya S, Yamamoto S, Kanamaru S, et al. Distribution of afaE adhesins in Escherichia coli isolated from Japanese patients with urinary tract infection. J Urol. 2003;169:1758-1761. (Pubitemid 36443490)
11. Johnson JR, Kuskowski MA, Gajewski A, et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis. 2005;191:46-50. (Pubitemid 40041399)
12. Parham NJ, Pollard SJ, Chaudhuri RR, et al. Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol. 2005;43:2425-2434. (Pubitemid 40656260)
13. Soto SM, Smithson A, Martinez JA, et al. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol. 2007;177:365-368. (Pubitemid 44895335)
14. Muller D, Greune L, Heusipp G, et al. Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl Environ Microbiol. 2007;73:3380-3390. (Pubitemid 46834990)
15. Zdziarski J, Svanborg C, Wullt B, et al. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun. 2008;76:695-703. (Pubitemid 351251741)
16. Nougayrède JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313: 848-851. (Pubitemid 44223356)
17. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555-4558.
18. Jaureguy F, Landreau L, Passet V, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics. 2008;9:560.
19. Wallace-Gadsden F, Johnson JR, Wain J, et al. Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg Infect Dis. 2007;13:757-760. (Pubitemid 46698740)
20. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5:449-456. (Pubitemid 36549187)
21. Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol. 2002;12:33-38. (Pubitemid 34033066)
22. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol. 2005;295:383-404. (Pubitemid 41226501)
23. Aoki SK, Pamma R, Hernday AD, et al. Contact-dependent inhibition of growth in Escherichia coli. Science. 2005;309:1245-1248. (Pubitemid 41170918)
24. Gillor O, Kirkup BC, Riley MA. Colicins and microcins: the next generation antimicrobials. Adv Appl Microbiol. 2004;54:129-146. (Pubitemid 38898745)
25. Roos V, Klemm P. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun. 2006;74:3565-3575. (Pubitemid 43794548)
26. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181:261-272. (Pubitemid 30049057)
27. Picard B, Garcia JS, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999;67:546-553. (Pubitemid 29059185)
28. Johnson JR, Johnston B, Kuskowski MA, et al. Molecular Epidemiology and phylogenetic Distribution of the Escherichia coli pks Genomic Island. J Clin Microbiol. 2008;46(12):3906-3911.
29. Le Gall T, Clermont O, Gouriou S, et al. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol. 2007;24: 2373-2384. (Pubitemid 350060443)
30. De Marzo AM, Nakai Y, Nelson WG. Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol. 2007;25:398-400. (Pubitemid 47362760)